Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 53Carcinoma, Non-Small-Cell Lung 36Urinary Bladder Neoplasms 31Neoplasm Metastasis 20Lung Neoplasms 20Ovarian Neoplasms 19Lymphoma, Large B-Cell, Diffuse 18Cholangiocarcinoma 15Triple Negative Breast Neoplasms 14Neoplasms 14Nasopharyngeal Carcinoma 14Biliary Tract Neoplasms 13Colorectal Neoplasms 12Carcinoma, Transitional Cell 12Breast Neoplasms 12Fallopian Tube Neoplasms 10Recurrence 9Gallbladder Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 8Bile Duct Neoplasms 7Sarcoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma 5Hodgkin Disease 5Endometrial Neoplasms 5Osteosarcoma 4Melanoma 4Gastrointestinal Neoplasms 4

Interventions

Bevacizumab 36atezolizumab 25durvalumab 22Nivolumab 21lenvatinib 20tremelimumab 15Specimen Handling 15Magnetic Resonance Spectroscopy 12sintilimab 11pembrolizumab 11Ipilimumab 10tislelizumab 7X-Rays 7Radiosurgery 7Immunoglobulin G 7regorafenib 6Sorafenib 6Disulfides 6Cyclophosphamide 6Radiotherapy 5cabozantinib 4Radiation 4Oxaliplatin 4Immunotherapy 4Fluorouracil 4Ethiodized Oil 4Blood Specimen Collection 4Biopsy 4fludarabine 3Photons 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Gemcitabine × 90 days × Clear all
NCT03017326 2026-05-13

PHITT

University of Birmingham

Phase 3 Active not recruiting
450 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT05775159 2026-04-17

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

AstraZeneca

Phase 2 Recruiting
294 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡